Antibiotic Selection for Uncomplicated Cellulitis
For typical nonpurulent cellulitis in adults, start with a beta-lactam antibiotic such as cephalexin 500 mg four times daily or dicloxacillin 500 mg four times daily for 5-10 days, targeting beta-hemolytic streptococci as the primary pathogen. 1
Clinical Classification Determines Antibiotic Choice
The critical first step is distinguishing between purulent and nonpurulent cellulitis, as this fundamentally changes your antibiotic selection 1:
Nonpurulent Cellulitis (Most Common)
- Presentation: Erythema, warmth, swelling, tenderness WITHOUT purulent drainage, exudate, or drainable abscess 1
- Primary pathogen: Beta-hemolytic streptococci (Group A Streptococcus) 1
- MRSA role: Uncommon cause; empirical MRSA coverage is NOT routinely needed 1
First-line oral options:
- Cephalexin 500 mg four times daily 1
- Dicloxacillin 500 mg four times daily 1
- Penicillin VK or amoxicillin 1
- Amoxicillin-clavulanate 875/125 mg twice daily 1
Duration: 5 days is as effective as 10 days if clinical improvement occurs by day 5 1
Purulent Cellulitis
- Presentation: Cellulitis WITH purulent drainage or exudate but NO drainable abscess 1
- Primary pathogen: Community-acquired MRSA (CA-MRSA) 1
- Streptococcal coverage: Likely unnecessary 1
Empirical MRSA-active oral options:
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily 1
- Doxycycline or minocycline 100 mg twice daily 1
- Clindamycin 300-450 mg three times daily 1
- Linezolid 600 mg twice daily 1
When to Add MRSA Coverage for Nonpurulent Cellulitis
Add MRSA coverage if:
- Patient fails to respond to beta-lactam therapy after 48-72 hours 1
- Systemic toxicity present (fever, hypotension, confusion) 1
- Penetrating trauma, especially injection drug use 1
- Known MRSA colonization or prior MRSA infection 2
Important caveat: A prospective study showed that beta-lactam therapy (cefazolin/oxacillin) was successful in 96% of typical cellulitis cases, confirming MRSA is an uncommon cause of nonpurulent cellulitis 1
Penicillin Allergy Management
For patients with penicillin allergy:
Non-immediate hypersensitivity (delayed rash):
Immediate hypersensitivity (anaphylaxis, urticaria, angioedema):
- Clindamycin 300-450 mg three times daily (covers both streptococci and MSSA) 1
- Doxycycline 100 mg twice daily PLUS amoxicillin (if dual coverage needed and allergy allows) 1
- TMP-SMX PLUS a beta-lactam alternative 1
Critical warning: TMP-SMX and doxycycline have uncertain activity against beta-hemolytic streptococci; do not use as monotherapy for nonpurulent cellulitis unless MRSA is strongly suspected 1
Dual Coverage Strategy (Streptococci + MRSA)
When both pathogens are concerns:
- Clindamycin 300-450 mg three times daily alone (covers both) 1
- TMP-SMX or doxycycline PLUS amoxicillin or cephalexin 1
- Linezolid 600 mg twice daily alone (covers both) 1
Note on clindamycin: Potential for inducible resistance in erythromycin-resistant MRSA strains; check local resistance patterns if clindamycin resistance exceeds 10% 1
Hospitalized Patients with Complicated Cellulitis
For severe/complicated cases requiring IV therapy:
- Vancomycin 30 mg/kg/day in 2 divided doses (for MRSA coverage) 1
- Cefazolin 1 g every 8 hours (for nonpurulent cellulitis, switch to MRSA-active if no response) 1
- Linezolid 600 mg IV/PO twice daily 1
- Daptomycin 4 mg/kg IV once daily 1
- Telavancin 10 mg/kg IV once daily 1
Duration for complicated cases: 7-14 days based on clinical response 1
Common Pitfalls to Avoid
Do NOT:
- Use rifampin as monotherapy or adjunctive therapy for cellulitis 1
- Routinely cover MRSA in typical nonpurulent cellulitis 1
- Use TMP-SMX or doxycycline alone for nonpurulent cellulitis without clear MRSA risk factors 1
- Treat beyond 5 days if clinical improvement achieved (for uncomplicated cases) 1
- Order blood cultures or imaging for typical uncomplicated cellulitis 1
DO obtain cultures when:
- Severe systemic features (high fever, hypotension) 1
- Immunosuppression, malignancy, neutropenia 1
- Failure to respond to initial therapy 1
- Purulent drainage present 1
Pediatric Considerations
Dosing adjustments for children:
- Cephalexin 25 mg/kg/day in 4 divided doses 1
- Dicloxacillin 25 mg/kg/day in 4 divided doses 1
- Clindamycin 10-20 mg/kg/day in 3 divided doses (oral) or 25-40 mg/kg/day IV 1
- Avoid tetracyclines in children <8 years 1
- Vancomycin 40 mg/kg/day in 4 divided doses IV (for hospitalized children with complicated SSTI) 1